NYSE:MED - Medifast Stock Price, News, & Analysis

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Medifast announced a quarterly dividend on Thursday, September 6th. Stockholders of record on Friday, September 21st will be given a dividend of $0.48 per share on Thursday, November 8th. This represents a $1.92 annualized dividend and a dividend yield of 0.94%. The ex-dividend date is Thursday, September 20th. View Medifast's Dividend History.

Medifast Inc (NYSE:MED) posted its quarterly earnings results on Thursday, August, 2nd. The specialty retailer reported $1.16 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.98 by $0.18. The specialty retailer earned $117.30 million during the quarter, compared to analyst estimates of $101.75 million. Medifast had a return on equity of 37.25% and a net margin of 10.87%. Medifast's revenue was up 55.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.63 earnings per share. View Medifast's Earnings History.

Medifast is scheduled to release their next quarterly earnings announcement on Tuesday, November 6th 2018. View Earnings Estimates for Medifast.

Medifast issued an update on its FY18 earnings guidance on Thursday, August, 2nd. The company provided EPS guidance of $4.35-4.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.67. The company issued revenue guidance of $460-470 million, compared to the consensus revenue estimate of $398.16 million.Medifast also updated its Q3 guidance to $1.05-1.10 EPS.

2 brokerages have issued 1 year price targets for Medifast's stock. Their forecasts range from $249.00 to $249.00. On average, they anticipate Medifast's stock price to reach $249.00 in the next twelve months. This suggests a possible upside of 22.1% from the stock's current price. View Analyst Price Targets for Medifast.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medifast.

Some companies that are related to Medifast include WANT WANT CHINA/ADR (WWNTY), Greencore Group (GNCGY), Farmer Bros (FARM), China Marine Food Group (CMFO) and Jammin Java (JAMN).

Medifast's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include MERIAN GLOBAL INVESTORS UK Ltd (1.21%), Aperio Group LLC (0.32%), Chickasaw Capital Management LLC (0.29%), Nisa Investment Advisors LLC (0.09%), Seven Eight Capital LP (0.08%) and KAMES CAPITAL plc (0.07%). Company insiders that own Medifast stock include Charles P Connolly, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.

MED stock was sold by a variety of institutional investors in the last quarter, including Aperio Group LLC, KAMES CAPITAL plc, Chickasaw Capital Management LLC, Strs Ohio and First Citizens Bank & Trust Co.. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Glenn W Welling and Michael C Macdonald. View Insider Buying and Selling for Medifast.

MED stock was bought by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, Seven Eight Capital LP, Nisa Investment Advisors LLC, Mitsubishi UFJ Asset Management UK Ltd., Louisiana State Employees Retirement System and State of Alaska Department of Revenue. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast.

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MED stock can currently be purchased for approximately $203.97.

Medifast has a market capitalization of $2.44 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe.

The official website for Medifast is http://www.medifast1.com.

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]